Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

6 results about "Chlamydia psittaci" patented technology

Chlamydia psittaci is a lethal intracellular bacterial species that may cause endemic avian chlamydiosis, epizootic outbreaks in mammals, and respiratory psittacosis in humans. Potential hosts include feral birds and domesticated poultry, as well as cattle, pigs, sheep, and horses. C. psittaci is transmitted by inhalation, contact, or ingestion among birds and to mammals. Psittacosis in birds and in humans often starts with flu-like symptoms and becomes a life-threatening pneumonia. Many strains remain quiescent in birds until activated by stress. Birds are excellent, highly mobile vectors for the distribution of chlamydia infection, because they feed on, and have access to, the detritus of infected animals of all sorts.

Chlamydia psittaci whole genome sequencing method and application thereof

The invention relates to a primer set for whole genome sequencing of chlamydia psittaci, the primer set comprises a primer subset p1 and a primer subset p2, the primer subset p1 comprises primers with sequences as shown in SEQ ID NO: 1-240, and the primer subset p2 comprises primers with sequences as shown in SEQ ID NO: 241-480. The primer group disclosed by the invention not only can accurately obtain the whole genome sequence of chlamydia psittaci, but also is adaptive to the sequencing modes of all second-generation and third-generation sequencing platforms.
Owner:BERGER (QINGDAO) MEDICAL TECH CO LTD

Pigeon source chlamydia psittaci and application thereof

PendingCN121930990AAntibacterial agentsBacteriaChlamydophilaVaccination
The invention belongs to the technical field of prevention and control of pigeon chlamydia disease, and particularly relates to pigeon source chlamydia psittaci and application thereof. The invention provides a strain of pigeon-derived chlamydia psittaci, and the collection number of the pigeon-derived chlamydia psittaci is CGMCC (China General Microbiological Culture Collection Center) No. 46418. The invention also provides a vaccine which contains the pigeon source chlamydia psittaci. According to the vaccine, the pigeons inoculated with the vaccine can effectively resist infection of chlamydia psittaci, the relative protection rate of the pigeons is 78.3%, and the vaccine has a good application prospect in the large-scale pigeon breeding industry.
Owner:BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES +1

Primer and probe set for detecting sheep abortion-causing bacteria and application of primer and probe set

The invention provides a primer and a probe group for detecting sheep abortion-causing bacteria and application of the primer and the probe group, and belongs to the technical field of biological detection. The primer and probe group is characterized in that the sequence of the primer and probe group for detecting the listeria is shown as SEQ ID NO.1-3, and the sequence of the probe group for detecting the listeria is shown as SEQ ID NO.2-3; according to the primer for detecting the salmonella abortus, the sequence of the probe group is as shown in SEQ ID NO.4-6; the sequences of the primer and the probe group aiming at Brucella detection are shown as SEQ ID NO.7-9; the sequence of a primer and a probe group for detecting chlamydia psittaci is as shown in SEQ ID NO.10-12. The invention further discloses a kit for detecting chlamydia psittaci. The method has the characteristics of visualization, high sensitivity, strong specificity, simplicity and convenience in operation, short time consumption and the like, realizes rapid differential diagnosis of four sheep bacterial abortion diseases through one-time PCR amplification, and has important advantages in the field of sheep disease diagnosis and identification.
Owner:CANGZHOU NORMAL UNIV +1

LAMP primer combination for detecting chlamydia psittaci and application of LAMP primer combination

The invention belongs to the field of prevention and control of psittaci diseases, and relates to an LAMP primer combination for detecting chlamydia psittaci and application of the LAMP primer combination. The invention provides an LAMP (loop-mediated isothermal amplification) primer combination for detecting chlamydia psittaci, and the LAMP primer combination comprises the following primers: FIP: 5 '-GTACATGTTTCAAGTTTATTGCCGATGCTAACAAATTTCAGAACAATTACAACAACAATTACAACAACGATTCCGC-3', BIP: 5 '-ACTTGGAAGCTATCTGTAGGTAAACAAGGAGA-3', F3: 5 '-GTATCTGCAACGGATCTG-3' and B3: 5 '-TCCTGTTAACGATTCCGC-3'. The primer combination can be used for LAMP detection of chlamydia psittaci, has the advantages of high sensitivity, strong specificity and
Owner:BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES

Convection amplification primer group, probe and kit for multiple detection of lower respiratory pathogens

The invention belongs to the field of biomedical treatment, and particularly relates to a convection amplification primer group, a probe and a kit for multiple detection of lower respiratory pathogens. The convection amplification primer pair comprises a legionella pneumophila primer pair, an adenovirus primer pair and a chlamydia psittaci primer pair, primer sequences in the legionella pneumophila primer pair, the adenovirus primer pair and the chlamydia psittaci primer pair respectively comprise a target nucleic acid complementary sequence and an interface sequence, and the interface sequence is located at the 5'end of the target nucleic acid sequence; the nucleic acid is not complementary with the target nucleic acid; the target nucleic acid complementary sequence has a folded sequence, and the folded sequence is complementary to the interface sequence, so that the primer sequence has a bent hairpin structure. Meanwhile, a primer probe is designed, and a respiratory tract pathogenic bacteria multiple detection kit is prepared. The multiple detection can avoid non-specific amplification and improve the detection sensitivity.
Owner:INNOVITA BIOLOGICAL TECH CO LTD +2

Multiplex detection of lower respiratory tract pathogens under the principle of probe and reagent kit for flow amplification

ActiveCN122038621BMultiplexChlamydophila
The application belongs to the field of biological medicine, and particularly relates to a multiplex detection lower respiratory tract pathogen counterflow amplification primer set, probe and kit. The counterflow amplification primer set comprises a Legionella pneumophila primer pair, an adenovirus primer pair and a Chlamydophila psittaci primer pair. The primer sequences in the Legionella pneumophila primer pair, the adenovirus primer pair and the Chlamydophila psittaci primer pair each comprise a target nucleic acid complementary sequence and an interface sequence. The interface sequence is located at the 5' end of the target nucleic acid sequence and is not complementary to the target nucleic acid. The target nucleic acid complementary sequence has a folding sequence, and the folding sequence is complementary to the interface sequence, so that the primer sequence has a curved hairpin structure. A primer probe is designed, and a respiratory tract pathogenic bacteria multiplex detection kit is prepared. The multiplex detection can avoid non-specific amplification and improve the detection sensitivity.
Owner:INNOVITA BIOLOGICAL TECH CO LTD +2